Finance Corcept loses patent spat against Teva, shares tumbleDecember 30, 20230 (Reuters) -A U.S. choose dominated in favor of Israel’s Teva Pharmaceutical Industries in a patent infringement lawsuit introduced by Corcept…
Finance Teva Stock Flirts With 200-Day Line After Beat And RaiseAugust 2, 20230 Early Tuesday, Teva Pharmaceutical (TEVA) reported adjusted earnings of 56 cents per share on $3.88 billion in second-quarter gross sales.…
